Catalyst Wire Dossier Catalyst Wire Dossier

Quantitative Refractive Crosslinking

· TECLens, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quantitative Refractive Crosslinking, covering 2025-08-29 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Quantitative Refractive Crosslinking in Presbyopia Aged Patients [NA]

See pricing